Indaptus Therapeutics, Inc. Announces One-for-Twenty-Eight Reverse Stock Split to Enhance Nasdaq Compliance and Attract Investors

Indaptus Therapeutics (INDP) announced a one-for-twenty-eight reverse stock split, effective June 27, 2025, primarily to regain compliance with Nasdaq's minimum bid price requirement and enhance appeal to institutional investors. This action will reduce the company's outstanding shares from approximately 16 million to about 572,000. While intended to strengthen the company's market position, such a significant reverse split often signals underlying financial distress and a need to avoid delisting, presenting a mixed signal to the market.

Analysis

Indaptus Therapeutics is conducting a one-for-twenty-eight reverse stock split effective June 27, 2025, a move designed to address its non-compliance with Nasdaq's minimum bid price. This action will consolidate the share count from approximately 16 million to about 572,000. While the company frames this as a strategy to attract institutional investors, such a significant split ratio is typically viewed as a measure to avoid delisting and often signals underlying operational or financial distress, a sentiment reinforced by a strongly negative sentiment score of -0.8 for the ticker. Recent institutional trading activity reflects this concern; although six firms added to their positions, eight decreased their holdings, with notable funds like Susquehanna, Two Sigma, and Citadel completely liquidating their stakes. This corporate action artificially inflates the share price but does not alter the company's fundamental valuation or address the root causes of its poor stock performance, and the drastic reduction in float could lead to heightened volatility.

Key Decisions for Investors

• Investors should treat this reverse stock split as a significant warning sign, as such actions are frequently followed by continued share price declines if not supported by positive fundamental developments.
• Monitor post-split trading volume and institutional holdings closely; the company's stated goal is to attract new institutions, so a failure to do so or a continuation of fund exits would be a strong bearish indicator.
• Given the complete exit of several institutional investors and the high risks associated with a 1-for-28 split, existing shareholders should reassess their position, while prospective investors should await tangible evidence of operational turnarounds before considering an entry.